Notification Letter with Request Form to Non-registered Holders

(incorporated in the Cayman Islands with limited liability) (于开曼群岛注册成立之有限公司) (Stock Code 股份代号: 1952) N OT IF IC ATI ON LET TE R 通 知 信 函 5 June 2024 (Note) Dear Non-registered holder Everest Medicines Limited (the “Company”) - Notice of Publication of Annual General Meeting Circular (the “Current Corporate Communication”) The English and Chinese versions of the Current Corporate Communication are available on the Company’s website at www.everestmedicines.com and are also available on the website of Hong Kong Exchanges and Clearing Limited (“HKEx”) at www.hkexnews.hk.If you would like to receive the Current Corporate Communication and all future Corporate Communications# in printed form please complete the Request Form on the reverse side of this letter and sign and return it by post or by hand to the Company c/o t he Company’s share registrar in Hong Kong (the “Hong Kong Share Registrar”) Computershare Hong Kong Investor Services Limited at 17M Floor Hopewell Centre 183 Queen’s Road East Wan Chai Hong Kong. If you post your reply in Hong Kong you may use the mailing label in the Request Form and need not affix a stamp on the envelope when returning your Request Form. Otherwise please affix an appropriate stamp. You may also send an email with a scanned copy of the Request Form to everestmedicines.ecom@computershare.com.hk. The Request Form may also be downloaded from the Company’s website at www.everestmedicines.com or the website of HKEx at www.hkexnews.hk.Should you have any questions in relation to this letter please call the telephone hotline of the Hong Kong Share Registrar at (852) 2862 8688 during business hours from 9:00 a.m. to 6:00 p.m. Monday to Friday excluding Hong Kong public holidays.Yours faithfully By Order of the Board Everest Medicines Limited Wei Fu Chairman and Executive Director Note: This letter is addressed to non-registered holders of the Company (a “non-registered holder” means such person or company whose shares in the Company are held in the Central Clearing and Settlement System (CCASS) and who has notified the Company from time to time through Hong Kong Securities Clearing Company Limited that such person or company wishes to receive Corporate Communications#). If you have sold or transferred all your shares in the Company please disregard this letter and the Request Form on the reverse side.# Corporate communications are all documents issued by the Company to holders of its securities for their information or action and include (but are not limited to) full and summary annual and interim financial reports (and all reports and financial statements contained in them) notices of meetings listing documents circulars and proxy forms.各位非登记持有人(附注)： 云顶新耀有限公司（「公司」） -股东周年大会通函（「本次公司通讯」）之发布通知 本次公司通讯之中、英文版本已上载于公司网站 (www.ev e re s tmed ic in es . co m)及香港交易及结算所有限公司（「香港交易所」）网站 (w ww.h k ex n ews .h k )，欢迎查阅。 如阁下欲收取本次公司通讯之印刷本及所有日后公司通讯#，请阁下填妥在本函背面的申请表格，并在申请表格上签名，然后把申请表格寄回或亲手交回香港中央证券登记有限公司（「香港证券登记处」），地址为香港湾仔皇后大道东 183 号合和中心 17M 楼。倘若 阁下在香港投寄，可使用申请表格内的邮寄标签寄回，而毋须在信封上贴上邮票；否则，请贴上适当的邮票。阁下亦可把已填妥之申请表格的扫描副本电邮至 everestmedicines.ecom@computershare.com.hk。申请表格亦可于公司网站(www.everestmedicines.com) 或香港交易所网站(www.hkexnews.hk)内下载。 阁下如有任何与本函内容有关的疑问，请致电香港证券登记处电话热线(852)28628688，办公时间为星期一至星期五（香港公众假期除外）上午9时正至下午6时正。 承董事会命云顶新耀有限公司主席兼执行董事傅唯谨启 2024年6月5日附注:本函件乃向本公司之非登记持有人（「非登记持有人」指本公司股份存放于中央结算及交收系统的人士或公司，透过香港中央结算有限公司不时向本公司发出通知表示该等人士或公司希望收到公司通讯#）发出。倘若阁下已出售或转让所持有的所有本公司股份，则无需理会本函及所附申请表格。 #公司通讯乃本公司向其证券持有人发出以供参照或采取行动的任何文件，包括但不限于年度和中期财务报告及其摘要报告（及其中包含的所有报告及财务报表）、会议通告、上市文件、通函及委任代表表格。CCS9198 EMLH_NRHName(s) and address of Non-registered holder(s) 非登记持有人之姓名及地址: Request Form 申请表格 To: Everest Medicines Limited (the “Company”) 致: 云顶新耀有限公司（「公司」） (Stock Code: 1952) （股份代号：1952） c/o Computershare Hong Kong Investor Services Limited 经香港中央证券登记有限公司 17M Floor Hopewell Centre 183 Queen’s Road East 香港湾仔皇后大道东 183 号 Wan Chai Hong Kong 合和中心 17M楼 I/We would like to receive corporate communications# from the Company in the manner indicated below: # 本人／我们欲以下列方式收取本公司之公司通讯（「公司通讯」）： (Please mark “X” in ONLY ONE of the following boxes) (请从下列选择中，仅在其中一个空格内划上「X」号)to receive all Corporate Communications in electronic form on the Company’s website at www.everestmedicines.com instead of receiving printed copies and to receive a printed notification letter for the publication of the relevant Corporate Communications on the website of the Company by post; OR 透过本公司网站 www.everestmedicines.com 收取所有的公司通讯电子本以代替收取印刷本，并以邮寄方式收取公司通讯文件已在网上刊发之通知信函印刷本；或 to receive the printed English version of all Corporate Communications by post ONLY; OR仅以邮寄方式收取所有公司通讯文件之英文印刷本；或 to receive the printed Chinese version of all Corporate Communications by post ONLY; OR仅以邮寄方式收取所有公司通讯文件之中文印刷本；或 to receive both the printed English and Chinese versions of all Corporate Communications by post. 以邮寄方式同时收取所有公司通讯文件之英文及中文印刷本。 _______________________________________________________________________________________________________________________________ Signature(s) Contact Phone Number Date签署联络电话号码日期 Notes 附注: 1. This letter is addressed to the non-registered shareholders whose shares are held in The Central Clearing and Settlement System (CCASS) and who have notified the Company from time to time through Hong Kong Securities Clearing Company Limited that they wish to receive Corporate Communications of the Company.本函件乃向非登记股东发出，该等人士的股份存放于中央结算及交收系统，而他们已经透过香港中央结算有限公司不时通知本公司，希望收取本公司公司通讯。 2. Any form with more than one box marked “X” with no box marked “X” with no signature or otherwise incorrectly completed will be void. 如在本表格作出超过一项选择、或未有作出选择、或未有签署、或在其他方面填写不正确，则本表格将会作废。 3. The above instruction will apply to the Corporate Communications to be sent to you unt il you notify to the Company c/o Computershare Hong Kong Investor Services Limited to the contrary or unless you have at anytime ceased to have ho ldings in the Company.上述指示适用于发送予阁下之公司通讯，直至阁下经香港中央证券登记有限公司通知本公司另作安排或除非阁下任何时候停止持有本公司的股份。 4. For the avoidance of doubt we do not accept any special instructions written on this Request Form. 为免存疑，任何在本申请表格上额外手写的指示，本公司将不予处理。 # Corporate communications are all documents issued by the Company to holders of its securities for their information or actio n and include (but are not limited to) full and summary annual and interim financial reports (and all reports and financial statements contained in them) notices of meetings listing documents circulars and proxy forms.公司通讯乃本公司向其证券持有人发出以供参照或采取行动的任何文件，包括但不限于年度和中期财务报告及其摘要报告（及其中包含的所有报告及财务报表）、会议通告、上市文件、通函及委任代表表格。 ?------------------------------------------------------ Mailing Label 邮寄标签 Please cut the mailing label and stick it on an envelope Get in touch with us 与我们联系 to return this Request Form to us. Send us an enquiry 垂询 Computershare Hong Kong Investor Services Limited No postage is necessary if posted in Hong Kong. Rate our service 评价 香港中央证券登记有限公司 Lodge a complaint 投诉 Contact Us 联系我们 Freepost No. 简便回邮号码：37 阁下寄回本申请表格时，请将邮寄标签剪贴于信封上。 Hong Kong 香港 如在本港投寄， 阁下无需支付邮费或贴上邮票。 www.computershare.com/hk/contactv.2 March 2016 ? 0506202410